Generation of Genetically-Modified Human Differentiated Cells for Toxicological Tests and the Study of Neurodegenerative Diseases

Lade...
Vorschaubild
Dateien
Schildknecht_256487_flat.pdf
Schildknecht_256487_flat.pdfGröße: 6.1 MBDownloads: 1083
Datum
2013
Herausgeber:innen
Kontakt
ISSN der Zeitschrift
Electronic ISSN
ISBN
Bibliografische Daten
Verlag
Schriftenreihe
Auflagebezeichnung
ArXiv-ID
Internationale Patentnummer
Link zur Lizenz
Angaben zur Forschungsförderung
Projekt
Open Access-Veröffentlichung
Open Access Gold
Sammlungen
Core Facility der Universität Konstanz
Gesperrt bis
Titel in einer weiteren Sprache
Forschungsvorhaben
Organisationseinheiten
Zeitschriftenheft
Publikationstyp
Zeitschriftenartikel
Publikationsstatus
Published
Erschienen in
Zusammenfassung

Human differentiated cell types, such as neurons or hepatocytes, are of limited availability, and their use for experiments requiring ectopic gene expression is challenging. Using the human conditionally-immortalized neuronal precursor line LUHMES, we explored whether genetic modification in the proliferating state could be used for experiments in the differentiated post-mitotic neurons. First, alpha-synuclein (ASYN), a gene associated with the pathology of Parkinson’s disease, was overexpressed. Increased amounts of the protein were tolerated without change of phenotype, and this approach now allows further studies on protein variants. Knockdown of ASYN attenuated the toxicity of the parkinsonian toxicant 1-methyl-4-phenylpyridinium (MPP+). Different lentiviral constructs then were tested: cells labeled ubiquitously with green (GFP) or red fluorescent protein (RFP) allowed the quantification of neurite growth and of its disturbance by toxicants; expression of proteins of interest could be targeted to different organelles; production of two different proteins from a single read-through construct was achieved successfully by an expression strategy using a linker peptide between the two proteins, which is cleaved by deubiquitinases; LUHMES, labeled with GFP in the cytosol and RFP in the mitochondria, were used to quantify mitochondrial mobility along the neurites. MPP+ reduced such organelle movement before any other detectable cellular change, and this toxicity was prevented by simultaneous treatment with the antioxidant ascorbic acid. Thus, a strategy has been outlined here to study new functional endpoints, and subtle changes of structure and proteostasis relevant in toxicology and biomedicine in post-mitotic human cells.

Zusammenfassung in einer weiteren Sprache
Fachgebiet (DDC)
570 Biowissenschaften, Biologie
Schlagwörter
LUHMES, dopaminergic neurons, alpha-synuclein, neurotoxicity
Konferenz
Rezension
undefined / . - undefined, undefined
Zitieren
ISO 690SCHILDKNECHT, Stefan, Christiaan KARREMAN, Dominik PÖLTL, Liudmila EFREMOVA, Cornelius KULLMANN, Simon GUTBIER, Anne K. KRUG, Diana SCHOLZ, Hanne R. GERDING, Marcel LEIST, 2013. Generation of Genetically-Modified Human Differentiated Cells for Toxicological Tests and the Study of Neurodegenerative Diseases. In: Alternatives to animal experimentation : ALTEX. 2013, 30(4), pp. 427-444. ISSN 1868-596X. Available under: doi: 10.14573/altex.2013.4.427
BibTex
@article{Schildknecht2013Gener-25648,
  year={2013},
  doi={10.14573/altex.2013.4.427},
  title={Generation of Genetically-Modified Human Differentiated Cells for Toxicological Tests and the Study of Neurodegenerative Diseases},
  number={4},
  volume={30},
  issn={1868-596X},
  journal={Alternatives to animal experimentation : ALTEX},
  pages={427--444},
  author={Schildknecht, Stefan and Karreman, Christiaan and Pöltl, Dominik and Efremova, Liudmila and Kullmann, Cornelius and Gutbier, Simon and Krug, Anne K. and Scholz, Diana and Gerding, Hanne R. and Leist, Marcel}
}
RDF
<rdf:RDF
    xmlns:dcterms="http://purl.org/dc/terms/"
    xmlns:dc="http://purl.org/dc/elements/1.1/"
    xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
    xmlns:bibo="http://purl.org/ontology/bibo/"
    xmlns:dspace="http://digital-repositories.org/ontologies/dspace/0.1.0#"
    xmlns:foaf="http://xmlns.com/foaf/0.1/"
    xmlns:void="http://rdfs.org/ns/void#"
    xmlns:xsd="http://www.w3.org/2001/XMLSchema#" > 
  <rdf:Description rdf:about="https://kops.uni-konstanz.de/server/rdf/resource/123456789/25648">
    <dc:contributor>Krug, Anne K.</dc:contributor>
    <dcterms:title>Generation of Genetically-Modified Human Differentiated Cells for Toxicological Tests and the Study of Neurodegenerative Diseases</dcterms:title>
    <dcterms:available rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2014-01-13T10:48:41Z</dcterms:available>
    <dc:rights>Attribution 4.0 International</dc:rights>
    <dc:contributor>Schildknecht, Stefan</dc:contributor>
    <dc:contributor>Kullmann, Cornelius</dc:contributor>
    <dc:creator>Leist, Marcel</dc:creator>
    <dc:contributor>Karreman, Christiaan</dc:contributor>
    <dc:creator>Krug, Anne K.</dc:creator>
    <dc:contributor>Pöltl, Dominik</dc:contributor>
    <bibo:uri rdf:resource="http://kops.uni-konstanz.de/handle/123456789/25648"/>
    <dspace:isPartOfCollection rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/28"/>
    <dc:creator>Efremova, Liudmila</dc:creator>
    <dcterms:bibliographicCitation>Alternatives to animal experimentation : ALTEX ; 30 (2013), 4. - S. 427-444</dcterms:bibliographicCitation>
    <void:sparqlEndpoint rdf:resource="http://localhost/fuseki/dspace/sparql"/>
    <dc:creator>Pöltl, Dominik</dc:creator>
    <dc:contributor>Scholz, Diana</dc:contributor>
    <dc:contributor>Gerding, Hanne R.</dc:contributor>
    <dspace:hasBitstream rdf:resource="https://kops.uni-konstanz.de/bitstream/123456789/25648/2/Schildknecht_256487_flat.pdf"/>
    <dcterms:abstract xml:lang="eng">Human differentiated cell types, such as neurons or hepatocytes, are of limited availability, and their use for experiments requiring ectopic gene expression is challenging. Using the human conditionally-immortalized neuronal precursor line LUHMES, we explored whether genetic modification in the proliferating state could be used for experiments in the differentiated post-mitotic neurons. First, alpha-synuclein (ASYN), a gene associated with the pathology of Parkinson’s disease, was overexpressed. Increased amounts of the protein were tolerated without change of phenotype, and this approach now allows further studies on protein variants. Knockdown of ASYN attenuated the toxicity of the parkinsonian toxicant 1-methyl-4-phenylpyridinium (MPP+). Different lentiviral constructs then were tested: cells labeled ubiquitously with green (GFP) or red fluorescent protein (RFP) allowed the quantification of neurite growth and of its disturbance by toxicants; expression of proteins of interest could be targeted to different organelles; production of two different proteins from a single read-through construct was achieved successfully by an expression strategy using a linker peptide between the two proteins, which is cleaved by deubiquitinases; LUHMES, labeled with GFP in the cytosol and RFP in the mitochondria, were used to quantify mitochondrial mobility along the neurites. MPP+ reduced such organelle movement before any other detectable cellular change, and this toxicity was prevented by simultaneous treatment with the antioxidant ascorbic acid. Thus, a strategy has been outlined here to study new functional endpoints, and subtle changes of structure and proteostasis relevant in toxicology and biomedicine in post-mitotic human cells.</dcterms:abstract>
    <foaf:homepage rdf:resource="http://localhost:8080/"/>
    <dcterms:isPartOf rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/28"/>
    <dcterms:rights rdf:resource="http://creativecommons.org/licenses/by/4.0/"/>
    <dc:contributor>Gutbier, Simon</dc:contributor>
    <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2014-01-13T10:48:41Z</dc:date>
    <dc:creator>Schildknecht, Stefan</dc:creator>
    <dc:contributor>Efremova, Liudmila</dc:contributor>
    <dc:creator>Gerding, Hanne R.</dc:creator>
    <dc:creator>Kullmann, Cornelius</dc:creator>
    <dc:creator>Scholz, Diana</dc:creator>
    <dc:language>eng</dc:language>
    <dc:creator>Gutbier, Simon</dc:creator>
    <dcterms:issued>2013</dcterms:issued>
    <dc:contributor>Leist, Marcel</dc:contributor>
    <dc:creator>Karreman, Christiaan</dc:creator>
    <dcterms:hasPart rdf:resource="https://kops.uni-konstanz.de/bitstream/123456789/25648/2/Schildknecht_256487_flat.pdf"/>
  </rdf:Description>
</rdf:RDF>
Interner Vermerk
xmlui.Submission.submit.DescribeStep.inputForms.label.kops_note_fromSubmitter
Kontakt
URL der Originalveröffentl.
Prüfdatum der URL
Prüfungsdatum der Dissertation
Finanzierungsart
Kommentar zur Publikation
Allianzlizenz
Corresponding Authors der Uni Konstanz vorhanden
Internationale Co-Autor:innen
Universitätsbibliographie
Ja
Begutachtet
Diese Publikation teilen